DWP
EW icon

Daymark Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Daymark Wealth Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Buy
22,629
+15,697
+226% +$1.31M 0.05% 244
2026
Q1 		$555K Sell
6,932
-412
-6% -$34K 0.02% 399
2025
Q4 		$626K Buy
7,344
+65
+0.9% +$5.33K 0.02% 350
2025
Q3 		$566K Sell
7,279
-1,049
-13% -$82K 0.02% 358
2025
Q2 		$651K Buy
8,328
+157
+2% +$11.7K 0.02% 312
2025
Q1 		$592K Buy
8,171
+58
+0.7% +$4.15K 0.03% 308
2024
Q4 		$601K Sell
8,113
-414
-5% -$29K 0.03% 296
2024
Q3 		$563K Sell
8,527
-6
-0.1% -$436 0.02% 315
2024
Q2 		$788K Buy
8,533
+656
+8% +$58.1K 0.04% 272
2024
Q1 		$753K Sell
7,877
-7
-0.1% -$588 0.04% 230
2023
Q4 		$601K Buy
7,884
+3,707
+89% +$258K 0.04% 240
2023
Q3 		$289K Buy
4,177
+334
+9% +$26.8K 0.02% 313
2023
Q2 		$363K Buy
3,843
+1,380
+56% +$120K 0.03% 276
2023
Q1 		$204K Buy
+2,463
New +$194K 0.03% 281

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Daymark Wealth Partners's EW Position: Q2 2026 in Review

Daymark Wealth Partners increased its Edwards Lifesciences (EW) stake by 226% in Q2 2026, buying an estimated $1.31M and bringing the position to 22,629 shares worth $2.05M. The position accounts for 0.05% of the portfolio, ranked #244.

Daymark Wealth Partners first reported a position in EW in Q1 2023 and has held it in 14 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Daymark Wealth Partners held 22,629 shares of Edwards Lifesciences worth $2.05M as of Q2 2026.
  • Daymark Wealth Partners bought 15,697 Edwards Lifesciences shares in Q2 2026, an estimated $1.31M.
  • Edwards Lifesciences made up 0.05% of Daymark Wealth Partners's portfolio in Q2 2026, its #244 holding.
  • Daymark Wealth Partners first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 14 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.